Copyright (c) 2010 Yahoo! Inc. All rights reserved.http://finance.yahoo.com/q/h?s=isisLatest Financial News for Isis Pharmaceuticals, Inc.en-usTue, 29 Dec 2009 15:47:37 Etc/GMThttp://us.news2.yimg.com/us.yimg.com/p/fi/pr/40197.gifhttp://finance.yahoo.com14417http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/zacks/091229/28776.html?.v=1As Isis had co-discovered OGX-011 with OncoGenex, Isis is entitled to receive $10 million of the upfront payment made by Teva to OncoGenexyahoo_finance/2651056163Tue, 29 Dec 2009 15:47:37 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/zacks/091228/28742.html?.v=1Teva Pharmaceutical Industries Ltd. recently entered into a global license and collaboration agreement with OncoGenex Pharmaceuticals, Inc.yahoo_finance/3451726771Mon, 28 Dec 2009 16:12:30 Etc/GMThttp://us.rd.yahoo.com/finance/external/pssa/rss/SIG=12s1ff4i7/*http%3A//seekingalpha.com/article/179753-teva-deal-a-reality-check-for-oncogenex-investors?source=yahooyahoo_finance/3575950062Thu, 24 Dec 2009 13:13:21 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/091221/us_teva_oncogenex_contract.html?.v=3Teva Pharmaceutical Industries Ltd. said Monday it will pay $60 million to OncoGenex Pharmaceuticals Inc. under terms of a new global licensing and partnership agreement covering OncoGenex's potential cancer treatment OGX-011.yahoo_finance/1656684937Tue, 22 Dec 2009 02:59:33 Etc/GMThttp://us.rd.yahoo.com/finance/external/reuters/rss/SIG=118cks9u6/*http%3A//www.reuters.com/legacyArticle?duid=mtfh57195_2009-12-21_16-32-47_sge5bk0fn_newsml&rpc=44&type=marketsNewsyahoo_finance/8618348Mon, 21 Dec 2009 16:32:47 Etc/GMThttp://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=137p3hkk2/*http%3A//www.thestreet.com/_yahoo/story/10650359/1/oncogenex-slammed-on-teva-partnership-biobuzz.html?cm_ven=YAHOO&cm_cat=FREE&cm_ite=NAyahoo_finance/613028045Mon, 21 Dec 2009 15:47:24 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/indie/091221/2661_id.html?.v=1Some big names got into the action on Monday.yahoo_finance/4129327475Mon, 21 Dec 2009 15:17:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091221/la29059.html?.v=1Isis Pharmaceuticals, Inc. today announced that it will receive a $10 million payment from OncoGenex Pharmaceuticals, Inc.   as a result of OncoGenex' license of OGX-011 to Teva Pharmaceutical Industries Ltd. .  OGX-011 is a second-generation antisense drug co-discovered by Isis and OncoGenex that has completed a successful Phase 2 program in patients with advanced prostate cancer and advanced non-small cell lung cancer.  Teva and OncoGenex will collaborate on a global Phase 3 clinical program for OGX-011 in patients with prostate and non-small cell lung cancer.yahoo_finance/506049152Mon, 21 Dec 2009 13:15:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/mfool/rss/SIG=12ndiotqs/*http%3A//www.fool.com/investing/general/2009/12/17/these-5-underdogs-are-no-dogs.aspx?source=eptyholnk303100&logvisit=y&npu=yyahoo_finance/57911138Thu, 17 Dec 2009 20:12:31 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091217/20091217005451.html?.v=1CARLSBAD, Calif.----Regulus Therapeutics Inc., founded by Alnylam Pharmaceuticals, Inc. and Isis Pharmaceuticals, Inc. , announced today that it has obtained exclusive rights from the California Institute of Technology to inventions made in the laboratory of David Baltimore, Ph.D. covering methods and compositions for modulating microRNA-146 and microRNA-155.yahoo_finance/1993117372Thu, 17 Dec 2009 13:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091215/20091215005577.html?.v=1CARLSBAD, Calif. & CAMBRIDGE, Mass.----Isis Pharmaceuticals, Inc. and Alnylam Pharmaceuticals, Inc. announced today that the United States Patent and Trademark Office has issued a Notice of Allowance for U.S. patent application in the “Crooke” patent family, which broadly covers chemically modified RNA-containing therapeutics.yahoo_finance/3262019329Tue, 15 Dec 2009 13:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/pssa/rss/SIG=12chq36gb/*http%3A//seekingalpha.com/article/178002-making-and-breaking-biotech-deals?source=yahooyahoo_finance/2162282514Mon, 14 Dec 2009 09:32:59 Etc/GMThttp://us.rd.yahoo.com/finance/external/mfool/rss/SIG=13aq4kj15/*http%3A//www.fool.com/investing/general/2009/12/11/4-star-stocks-poised-to-pop-isis-pharmaceuticals.aspx?source=eptyholnk303100&logvisit=y&npu=yyahoo_finance/2729713872Fri, 11 Dec 2009 15:12:47 Etc/GMThttp://us.rd.yahoo.com/finance/external/mfool/rss/SIG=12k8erlng/*http%3A//www.fool.com/investing/general/2009/12/09/3-stocks-hitting-low-notes.aspx?source=eptyholnk303100&logvisit=y&npu=yyahoo_finance/3449810294Wed, 9 Dec 2009 19:49:23 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091209/20091209005493.html?.v=1CARLSBAD, Calif.----Regulus Therapeutics Inc., founded by Alnylam Pharmaceuticals, Inc. , and Isis Pharmaceuticals, Inc. , unveiled plans for an educational webinar about microRNA biology that will highlight several recent exciting discoveries in the field and showcase the therapeutic strategies based on microRNA.yahoo_finance/2607296772Wed, 9 Dec 2009 13:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091208/isis8-k.htmlyahoo_finance/2713654296Tue, 8 Dec 2009 21:18:08 Etc/GMThttp://us.rd.yahoo.com/finance/external/barrons/rss/SIG=11vk9j29a/*http%3A//online.barrons.com/article/SB125978782546873299.html?ru=yahoo&mod=yahoobarronsGenzyme Held Back by Supply Problems Hapoalim initiated coverage of the drug maker at Hold.yahoo_finance/1740574006Thu, 3 Dec 2009 22:33:05 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091203/la20177.html?.v=1Isis Pharmaceuticals, Inc. announced today that it has added two new drugs to its development pipeline, ISIS-FXIRx and ISIS-SMNRx.yahoo_finance/3737567490Thu, 3 Dec 2009 13:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=131d8jjpe/*http%3A//www.thestreet.com/_yahoo/story/10634372/1/biotech-calendar-key-dates-for-december.html?cm_ven=YAHOO&cm_cat=FREE&cm_ite=NAyahoo_finance/1452767871Mon, 30 Nov 2009 14:56:24 Etc/GMThttp://us.rd.yahoo.com/finance/external/pssa/rss/SIG=13kgkjh7s/*http%3A//seekingalpha.com/article/175269-genzyme-s-renagel-renvela-franchise-investors-would-be-wise-to-reevaluate?source=yahooyahoo_finance/2903074468Wed, 25 Nov 2009 12:31:44 Etc/GMT